drugset / Trial / NCT00430586

Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines

NCT00430586 ↗

Phase 2 Completed 191 enrolled Merz Pharmaceuticals GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

NT 201 is a botulinum toxin type A preparation free of complexing proteins, i.e. free of proteins other than the active toxin. Injected into the muscle, NT 201 causes local weakening to full paralysis depending on the administered dose. Botulinum toxin type A is widely used for aesthetic treatment of facial lines. This study will determine the optimal dose of NT 201 in the treatment of glabellar frown lines.

Timeline

Start
2006-11
Primary completion
—
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 10 unknown Other
Subject Botulinum toxin type A Protein / enzyme biologic 20 unknown Other
Subject Botulinum toxin type A Protein / enzyme biologic 30 unknown Other

Indications

No indication recorded.